What is the Gorlin Formula?
The Gorlin formula is a hemodynamic equation used in cardiology to calculate the effective orifice area of a stenotic cardiac valve. It relies on data obtained during cardiac catheterization, specifically cardiac output, heart rate, the duration of flow across the valve per cardiac cycle, and the mean transvalvular pressure gradient. The formula converts these measurements into an estimate of the valve opening area in square centimeters, which is the primary metric for grading the severity of valvular stenosis.
Valvular stenosis occurs when a heart valve becomes thickened, stiff, or fused, restricting the flow of blood through its orifice. The two most commonly evaluated valves using the Gorlin formula are the mitral valve (between the left atrium and left ventricle) and the aortic valve (between the left ventricle and the aorta). By quantifying how narrow the valve opening has become, clinicians can make informed decisions regarding medical management or surgical intervention.
Despite advances in echocardiography and non-invasive imaging, the Gorlin formula remains the gold standard for invasive hemodynamic assessment of valve stenosis, particularly when non-invasive studies are inconclusive or discordant with clinical findings. It is an essential tool in the catheterization laboratory and continues to be taught in cardiology fellowship training programs worldwide.
History and Development
The formula was developed by Dr. Richard Gorlin and his father, Dr. S. Gorlin, and published in the American Heart Journal in 1951. Their seminal paper, "Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts," introduced a method adapted from hydraulic engineering principles—specifically, the Torricelli orifice equation—to the clinical setting of cardiac valve disease.
The Gorlins recognized that blood flow through a stenotic valve behaves similarly to fluid flow through a fixed orifice. By applying Bernoulli's principle and incorporating empirical correction constants derived from clinical validation studies, they created a formula that could transform catheterization-derived hemodynamic measurements into a clinically meaningful valve area. The original empirical constants (37.7 for the mitral valve and 44.3 for the aortic valve) were derived by comparing the formula's predictions with valve areas measured at surgery or autopsy.
Over the decades, the Gorlin formula has been validated extensively, though researchers have also identified its limitations, leading to modifications such as the Hakki formula (a simplified version) and the development of the continuity equation for echocardiographic assessment. Nevertheless, the original Gorlin formula remains widely used when invasive hemodynamic data are available.
The Gorlin Formula Explained
The general form of the Gorlin formula calculates valve area (VA) from the transvalvular flow rate divided by the product of an empirical constant and the square root of the mean pressure gradient across the valve:
Where:
- Flow = Cardiac Output / (Period × Heart Rate), expressed in mL/sec
- C = Empirical constant (37.7 for mitral valve, 44.3 for aortic valve)
- ΔP = Mean transvalvular pressure gradient in mmHg
For the mitral valve, the relevant period is the diastolic filling period (DFP)—the time during each cardiac cycle when blood flows from the left atrium into the left ventricle:
For the aortic valve, the relevant period is the systolic ejection period (SEP)—the time during each cardiac cycle when blood is ejected from the left ventricle into the aorta:
The empirical constants account for the coefficient of contraction and the coefficient of velocity. For the mitral valve, the product of these coefficients was determined to be approximately 0.85, which when combined with the gravitational constant and unit conversions yields 37.7. For the aortic valve, the constant is 44.3 due to different flow dynamics across the semilunar valve.
Mitral Stenosis Grading
Mitral stenosis severity is graded based on the calculated mitral valve area (MVA). The normal mitral valve area in adults is approximately 4 to 6 cm². As the valve narrows due to rheumatic heart disease or other causes, symptoms progressively worsen.
| Severity | Valve Area (cm²) | Mean Gradient (mmHg) | Symptoms |
|---|---|---|---|
| Normal | 4.0 – 6.0 | < 2 | None |
| Mild Stenosis | 1.5 – 2.5 | 2 – 5 | Dyspnea with strenuous activity |
| Moderate Stenosis | 1.0 – 1.5 | 5 – 12 | Dyspnea with moderate activity |
| Severe Stenosis | < 1.0 | > 12 | Dyspnea at rest, pulmonary edema |
Patients with a mitral valve area below 1.5 cm² are generally considered to have hemodynamically significant stenosis, and those with areas below 1.0 cm² are candidates for percutaneous mitral balloon commissurotomy or surgical valve replacement if symptomatic.
Aortic Stenosis Grading
Aortic stenosis is one of the most common valvular heart diseases in developed countries, primarily affecting elderly patients with calcific degeneration. The normal aortic valve area is approximately 3 to 4 cm².
| Severity | Valve Area (cm²) | Mean Gradient (mmHg) | Peak Jet Velocity (m/s) |
|---|---|---|---|
| Normal | 3.0 – 4.0 | < 5 | < 2.0 |
| Mild Stenosis | 1.5 – 2.0 | < 25 | 2.0 – 2.9 |
| Moderate Stenosis | 1.0 – 1.5 | 25 – 40 | 3.0 – 3.9 |
| Severe Stenosis | < 1.0 | > 40 | ≥ 4.0 |
An aortic valve area below 1.0 cm² is generally considered severe stenosis. Combined with symptoms such as syncope, angina, or heart failure, this threshold is a class I indication for aortic valve replacement according to ACC/AHA guidelines. Very severe stenosis is defined as an AVA below 0.6 cm².
Clinical Applications
The Gorlin formula is used in several clinical scenarios:
- Discordant non-invasive findings: When echocardiographic data conflict—for example, a low mean gradient but a small valve area by the continuity equation—cardiac catheterization with the Gorlin formula can resolve the discrepancy.
- Pre-surgical assessment: Before valve replacement surgery, precise hemodynamic measurements confirm the severity of stenosis and guide the choice of prosthetic valve size.
- Low-flow, low-gradient aortic stenosis: In patients with reduced left ventricular ejection fraction, the Gorlin formula can be applied during dobutamine stress catheterization to differentiate true severe stenosis from pseudo-severe stenosis.
- Combined valvular disease: When multiple valves are affected, the Gorlin formula can be applied to each valve individually using the appropriate hemodynamic parameters.
- Research and clinical trials: The formula provides a standardized method for quantifying valve stenosis severity across studies and in multicenter clinical trials of new interventional procedures.
Limitations and Pitfalls
While the Gorlin formula remains an important clinical tool, it has several well-known limitations that clinicians must consider:
- Flow dependence: The calculated valve area varies with cardiac output. In low-flow states, the formula may underestimate the true anatomic valve area, and in high-flow states (such as significant aortic regurgitation), it may overestimate the area.
- Pressure recovery: The formula does not account for pressure recovery distal to the stenotic orifice, which can lead to overestimation of the gradient and underestimation of the valve area, particularly in small aortic roots.
- Irregular heart rhythms: Atrial fibrillation causes beat-to-beat variation in flow and gradient. Averaging over at least 10 cardiac cycles is recommended, but this introduces additional measurement error.
- Concomitant regurgitation: The formula uses forward cardiac output. If significant valvular regurgitation is present, the total flow across the valve is greater than the net forward output, leading to underestimation of the valve area.
- Empirical constants: The constants 37.7 and 44.3 were derived from a limited number of patients and may not be universally applicable across all populations and valve morphologies.
- Measurement errors: Accurate determination of cardiac output (by thermodilution or Fick method), pressure gradients (requiring high-fidelity catheters), and flow periods (requiring precise timing from pressure tracings) is essential. Small errors in these measurements can propagate significantly.
Worked Example
Consider a patient with suspected mitral stenosis. Cardiac catheterization reveals:
- Cardiac Output: 4,800 mL/min
- Heart Rate: 75 bpm
- Diastolic Filling Period: 0.32 sec/beat
- Mean Transmitral Gradient: 12 mmHg
MVA = 200 / (37.7 × √12) = 200 / (37.7 × 3.464) = 200 / 130.6 = 1.53 cm²
This mitral valve area of 1.53 cm² falls in the mild-to-moderate stenosis range. The patient should be monitored closely, and intervention should be considered if symptoms progress or if the valve area decreases on follow-up assessment.
Frequently Asked Questions
What is the Gorlin formula used for?
The Gorlin formula calculates the effective orifice area of a stenotic heart valve using data from cardiac catheterization. It helps cardiologists determine the severity of mitral or aortic stenosis and guides decisions about medical management versus surgical or percutaneous intervention.
How accurate is the Gorlin formula?
The Gorlin formula has been validated against surgical and autopsy valve areas with reasonable accuracy, typically within 0.1 to 0.2 cm² of the true area. However, accuracy decreases in low-flow states, irregular heart rhythms, and when significant valvular regurgitation coexists with stenosis.
What is the difference between the Gorlin and Hakki formulas?
The Hakki formula is a simplified version: Valve Area = CO (L/min) / √(Peak-to-Peak Gradient). It eliminates the need for heart rate and flow period measurements but is less accurate in tachycardia (HR > 100) or bradycardia (HR < 60). The Gorlin formula is more precise when all hemodynamic parameters are accurately measured.
Why are the constants different for mitral and aortic valves?
The empirical constants (37.7 for mitral, 44.3 for aortic) reflect differences in the coefficient of orifice contraction and velocity coefficient between the two valve types. These were derived from comparisons with directly measured valve areas and account for the different hemodynamic environments of diastolic filling (mitral) versus systolic ejection (aortic).
Can the Gorlin formula be used for tricuspid or pulmonary valve stenosis?
In principle, yes. The Gorlin formula can be adapted for right-sided valves by using the appropriate cardiac output, heart rate, flow period, and pressure gradient. However, it is less commonly applied to the tricuspid and pulmonary valves because stenosis of these valves is relatively rare and echocardiographic assessment is usually sufficient.
What role does echocardiography play compared to the Gorlin formula?
Echocardiography is the first-line non-invasive tool for assessing valve stenosis using Doppler-derived gradients and the continuity equation. The Gorlin formula is reserved for invasive assessment during cardiac catheterization, typically when echocardiographic results are inconclusive, discordant with clinical findings, or when catheterization is performed for other reasons (such as coronary angiography prior to surgery).